These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7629641)
1. Relationship of local i.v. complications and the method of intermittenti.v. access. Hunter ES; Bell E; Staub MA; Coyle G J Intraven Nurs; 1995; 18(4):202-6. PubMed ID: 7629641 [TBL] [Abstract][Full Text] [Related]
2. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents. Garrelts JC; Ast D; LaRocca J; Smith DF; Peterie JD Clin Pharm; 1988 Oct; 7(10):760-5. PubMed ID: 3233896 [TBL] [Abstract][Full Text] [Related]
3. The impact of an i.v. team on the occurrence of intravenous-related phlebitis. A 30-month study. Scalley RD; Van CS; Cochran RS J Intraven Nurs; 1992; 15(2):100-9. PubMed ID: 1564603 [TBL] [Abstract][Full Text] [Related]
4. Thrombotic complications in intravenous access. Smith JP J Intraven Nurs; 1998; 21(2):96-100. PubMed ID: 9601316 [TBL] [Abstract][Full Text] [Related]
6. Preventing infection during i.v. therapy. Wilson JA Prof Nurse; 1994 Mar; 9(6):388-90, 392. PubMed ID: 8197214 [TBL] [Abstract][Full Text] [Related]
7. 9 common i.v. complications and what to do about them. Bohony J Am J Nurs; 1993 Oct; 93(10):45-9. PubMed ID: 8213945 [No Abstract] [Full Text] [Related]
8. Practical and professional aspects of i.v. therapy. Scales K Prof Nurse; 1997 May; 12(8 Suppl):S3-5. PubMed ID: 9180590 [TBL] [Abstract][Full Text] [Related]
9. Intravenous fluid therapy: a randomized controlled trial to investigate the effectiveness of the IV(2) flow medical device. Fraser N; Snyman JR; Wessels F; Nel G J Clin Nurs; 2007 Sep; 16(9):1593-601. PubMed ID: 17727580 [TBL] [Abstract][Full Text] [Related]
10. Monitoring i.v.-site infections. Brannen S; Surette D Can Nurse; 1997 Mar; 93(3):49-50. PubMed ID: 9110638 [TBL] [Abstract][Full Text] [Related]
11. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection]. Weber M; Meyer F; Halloul Z Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684 [TBL] [Abstract][Full Text] [Related]
13. Intravenous sites and fluids. Huber D Gastroenterol Nurs; 2008; 31(3):233-4. PubMed ID: 18542025 [No Abstract] [Full Text] [Related]
14. I.v.-related phlebitis, complications and length of hospital stay: 1. Campbell L Br J Nurs; 1998 Nov 26-Dec 9; 7(21):1304-6, 1308-12. PubMed ID: 10076204 [TBL] [Abstract][Full Text] [Related]
15. [Septic phlebitis: origin of severe septic condition]. Espinoza R; Andresen M; Nervi B; Rosemberg H Rev Med Chil; 1998 Feb; 126(2):195-8. PubMed ID: 9659756 [TBL] [Abstract][Full Text] [Related]
16. [Peripheral I.V. therapy and nursing]. Chen YC; Huang MC Hu Li Za Zhi; 2006 Jun; 53(3):69-72. PubMed ID: 16767625 [TBL] [Abstract][Full Text] [Related]
17. A better way to chart i.v. therapy. Newton GA RN; 1988 Jul; 51(7):26-8. PubMed ID: 3387836 [No Abstract] [Full Text] [Related]
18. Documenting i.v. therapy, Part I. Nursing; 2000 Feb; 30(2):73. PubMed ID: 11000847 [No Abstract] [Full Text] [Related]